The primary end point was event-free survival (EFS).
2
在延长无病生存期方面中西医结合治疗略有优势，但尚无统计学意义。
In the extended disease-free survival in Integrated Treatment slight advantage, but there is no statistical significance.
3
目的观察剂量密度化疗治疗乳腺癌的不良反应及对无病生存期和总生存期的影响。
Objective to investigate the adverse effect, disease free survival and overall survival of dose-dense chemotherapy in postoperative breast cancer patients.
点击反馈